Please ensure Javascript is enabled for purposes of website accessibility

Intuitively Waiting

By Brian Orelli, PhD – Updated Apr 6, 2017 at 2:24AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Systems sales are down; no surprise there.

Investors got an early-morning present from Intuitive Surgical (NASDAQ:ISRG) yesterday, when the company's vendor submitted the 8-K early -- before the press release went out -- but the quarterly update was all about revenue that will be recognized later.

The maker of robotic surgical systems introduced a new model this month. The system has a sharper image, so surgeons can better see what they're working on. The new setup can also include a second console, which should facilitate teaching and complex procedures that might require two surgeons. In addition to sporting a higher list price, the new system should drive procedure growth, because it'll be easier to train new surgeons, and it may be possible to develop complex procedures that can't currently be done with just one surgeon.

To avoid upsetting 44 customers that ordered the best system available last quarter, Intuitive Surgical offered to sell them a discounted upgrade, which resulted in $20 million in deferred revenue.

In total, the company sold 66 systems this first quarter, compared to 74 in the first quarter of last year. While it's certainly not welcome, the drop isn't too surprising; medical device makers like Natus Medical (NASDAQ:BABY), Stryker (NYSE:SYK), and Medtronic (NYSE:MDT) have had a rough time as hospitals tighten capital spending. More encouragingly, the level of international sales actually went up this quarter, from 20 systems in the first quarter of last year to 22 systems this year. That's certainly good news, and it suggests that Intuitive has plenty of international growth left.

While system sales didn't produce the same crazy growth we've seen in the past, the same couldn't be said for the revenue derived from the machines once they're installed. Instrument and accessory sales were up 28.6%, and revenue from service contracts grew by 44.3%, thanks to the increased number of installed instruments compared to a year earlier and the 60% growth in procedure volume. Much like Microsoft's (NASDAQ:MSFT) Xboxes and Hewlett-Packard's (NYSE:HPQ) printers, Intuitive Surgical's systems drive sales of accessories long after the initial sale has closed.

This will clearly be a tough year for the Rule Breakers recommendation, and almost everyone else for that matter, but the company should make it through O.K. Once hospitals are no longer so worried about their budgets, it might even see some pent-up demand.

Cut through this Foolishness:

Find out why Intuitive Surgical has been recommended four times by our Rule Breakers newsletter. Click here to grab a free 30-day trial subscription and get the latest issue as well as access to the archives.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. Microsoft and Stryker are Inside Value selections. Natus Medical is a Motley Fool Hidden Gems recommendation. The Fool owns shares of Stryker and has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$190.52 (-0.29%) $0.56
HP Inc. Stock Quote
HP Inc.
HPQ
$25.35 (-1.40%) $0.36
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.92 (-1.27%) $-3.06
Stryker Corporation Stock Quote
Stryker Corporation
SYK
$206.93 (-0.93%) $-1.95
Medtronic plc Stock Quote
Medtronic plc
MDT
$82.66 (-1.08%) $0.90
Natus Medical Incorporated Stock Quote
Natus Medical Incorporated
NTUS

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.